Nobel laureate: Ethics debate unstilled by stemcell success

Nov 12, 2012 by Olivier Thibault
Japanese Kyoto University professor Shinya Yamanaka, who won the 2012 Nobel Prize in Medicine with John B. Gurdon of Britain, answers to journalists' questions in Paris. Yamanaka cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

Newly-crowned Nobel laureate Shinya Yamanaka on Monday cautioned that stem cells could still spur sharp debate, despite his achievement in creating cells that are not derived from embryos.

The Japanese scientist was interviewed on a trip to Paris after co-winning the 2012 Nobel Prize for Medicine last month alongside Britain's John Gurdon.

Yamanaka was lauded for "reprogramming" so that they return to a versatile primitive state, called stem cells.

Researchers hope that stem cells may one day provide lab-grown tissue to replenish organs damaged by accident or disease.

Only the very first steps have been taken along this road, but the mission has been boosted by Yamanaka's work, for it implies that culled from embryos—until now the most potent but also a highly controversial source—may no longer be needed.

But Yamanaka warned that his induced (iPS) are unlikely to escape a storm touching on the creation of life.

"Now we can avoid the use of , so it's good. However, we are facing new ," he told AFP.

The question, he said, lies with the creation of so-called —cells that give rise to sperm or eggs.

"Can we make sperm from blood and can we fertilise these oocytes (eggs)?" he asked. "We really need discussion in society about how much we can do about this new technology."

Yamanaka said scientists in Kobe had already applied to the Japanese authorities for permission to carry out the world's first iPS trial on humans, using cells on patients suffering from .

And, he said, Japan was pushing ahead with a stem cell bank, which was approved in July.

"In theory, we can make iPS cells from each patient. But it would be very expensive and take six months to prepare the cells from each patient. So in reality, we cannot do that," he said.

A stem cell bank would be a good alternative, said Yamanaka.

The idea is to choose donors whose is least likely to trigger rejection by a patient's immune system.

"We may be able to cover many patients by having only a handful of iPS stock, that's our plan," he said. "By our estimations, we identified 140 such specific donors, (and with these) we could cover up to 90 percent of the whole population."

Some scientists have been cautious about iPS technology, fearing that reprogramming errors as an adult cell is rewound to its infant state, using a batch of introduced genes, could cause tumours.

Yamanaka, 50, carried out his groundbreaking work in 2007, but was quick to pay tribute to Gurdon, who laid the conceptual foundations in 1962.

In 2007, "We thought maybe we will win the Nobel prize in the future if it goes" to clinical trials, he said.

"So we did not expect (it) at this time because it was too early. But we were awarded because of Sir John Gurdon and his discovery 50 years ago... Because of him I was very lucky to be awarded."

Explore further: Life's extremists may be an untapped source of antibacterial drugs

add to favorites email to friend print save as pdf

Related Stories

Japan Nobel laureate gets washing machine as gift

Oct 19, 2012

Japan's Shinya Yamanaka may have won $1.2 million along with British researcher John Gurdon when the two were awarded the Nobel Prize for medicine earlier this month, but now he is also getting a new washing machine.

The future of stem cell research

Dec 08, 2010

Perhaps no single scientist has had a greater impact on stem cell research than Dr. Shinya Yamanaka. While most of his colleagues were looking for ways to grow human embryonic stem cells into replacement tissues for treating ...

Critical process in stem cell development identified

Jul 05, 2012

Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell--called an iPS cell--that is derived from adult skin cells. This discovery offers newfound ...

Recommended for you

Cohesin molecule safeguards cell division

Nov 21, 2014

The cohesin molecule ensures the proper distribution of DNA during cell division. Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna can now prove the concept of its carabiner-like ...

Nail stem cells prove more versatile than press ons

Nov 21, 2014

There are plenty of body parts that don't grow back when you lose them. Nails are an exception, and a new study published in the Proceedings of the National Academy of Sciences (PNAS) reveals some of the r ...

Scientists develop 3-D model of regulator protein bax

Nov 21, 2014

Scientists at Freie Universität Berlin, the University of Tubingen, and the Swiss Federal Institute of Technology in Zurich (ETH) provide a new 3D model of the protein Bax, a key regulator of cell death. When active, Bax ...

Researchers unwind the mysteries of the cellular clock

Nov 20, 2014

Human existence is basically circadian. Most of us wake in the morning, sleep in the evening, and eat in between. Body temperature, metabolism, and hormone levels all fluctuate throughout the day, and it ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.